APA (7th ed.) Citation

S, B., E, L., MP, H., A, G., H, S., A, J., . . . S, D. (2024). Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma. Journal for immunotherapy of cancer, 12(7), . https://doi.org/10.1136/jitc-2024-008975

Chicago Style (17th ed.) Citation

S, Bharadwaj, et al. "Bendamustine Is a Safe and Effective Lymphodepletion Agent for Axicabtagene Ciloleucel in Patients with Refractory or Relapsed Large B-cell Lymphoma." Journal for Immunotherapy of Cancer 12, no. 7 (2024). https://doi.org/10.1136/jitc-2024-008975.

MLA (9th ed.) Citation

S, Bharadwaj, et al. "Bendamustine Is a Safe and Effective Lymphodepletion Agent for Axicabtagene Ciloleucel in Patients with Refractory or Relapsed Large B-cell Lymphoma." Journal for Immunotherapy of Cancer, vol. 12, no. 7, 2024, https://doi.org/10.1136/jitc-2024-008975.